Title: Chief Executive Officer
Company: Proton Referral Network
Location: Suwanee, Georgia, United States
Jeremy Gilden, chief executive officer of Proton Referral Network, has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in health care.
Mr. Gilden is distinguished for his success as the chief executive officer of Proton Referral Network, an organization devoted to bringing proton therapy to facilities and patients. The company recently became an independent entity of its parent company, Proton International, in 2023, which has been in business for over 10 years and provides advanced radiation therapy to cancer patients. Mr. Gilden continues to focus on managing international referrals, which he oversaw previously during his tenure at Proton International. He also oversees the development of new proton center facilities, collaborates with health care partners to create such centers and coordinates with country managers in places like Turkey, Brazil and South Africa to gain access to proton therapy for patients in regions that lack local treatment options.
Leveraging his expertise in international health care policies and clinical pathways for patient care, Mr. Gilden has held several other significant roles that led him to where he is today. Since 2013, he has served as the project development manager for Healthcare Technologies International. He has also been excelling as the director of sales and business development at HTI- Sports Diagnostics since 2020. Besides his work in this sector, Mr. Gilden has been the chief operating officer of Terra di Siena USA since 2013, an Italian meat product company based in Virginia.
A graduate of the University of Georgia, Mr. Gilden received a Bachelor of Arts in speech communications in 2008. Throughout his career, he has been grateful for his various contributions, including his role in successfully treating the first Turkish patient approved for proton treatment by his government in 2017. This life-saving treatment for a brain tumor took place in the U.S., was profoundly impactful for Mr. Gilden and continues to drive him today. As he prepares for the Proton Referral Network’s future, he aims to secure several more government contracts in other countries with health care coverage for proton therapy and continue making a difference on a global scale.
For more information, please visit:
Contact Mr. Gilden:
